Have you ever wondered what it takes to get a new drug to market?
The FDA drug approval process is a critical pathway that ensures safety and efficacy before new treatments reach the public.
In our latest discussion, Josh Wilson speaks with Allan Shaw about the intricate steps involved, from filing an IND application to conducting thorough Phase 1, 2, and 3 trials.
Whether you're interested in the biotechnology field or just curious about the pharmaceutical industry's inner workings, this conversation sheds light on the dedication and precision required to bring new drugs to market. Don't miss out on this insightful discussion.
Tune in now! #PharmaceuticalIndustry
#FDADrugApproval #HealthcareInnovation
Disclaimer: Joshua Wilson is a licensed Florida real estate broker and holds FINRA Series 79 and Series 63 licensure. The content of this podcast is for informational and educational purposes only and should not be considered legal, financial, or compliance advice. All views and opinions expressed by the host and guests are their own and do not necessarily reflect the policies or positions of any regulatory agency, organization, or employer. Listeners should consult their own legal counsel, compliance teams, or financial advisors to ensure adherence to applicable regulations, including SEC, FINRA, and other industry-specific requirements. This podcast does not constitute a solicitation or recommendation for any financial products or services.
Let’s Connect on LinkedIn:
https://www.linkedin.com/in/joshuabrucewilson/
To Contact Us, Please Visit:
